MONICA ECKMAN: Open Payments
NPI 1619136967 · SOMERS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 39 payments from 12 companies in 2025. Trend: 2023 $297 · 2024 $404 · 2025 $693
Food & beverage: $593Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GlaxoSmithKline, LLC. | 5 | $82 |
| JAZZ PHARMACEUTICALS INC. | 4 | $75 |
| Verona Pharma, Inc. | 3 | $57 |
| HARMONY BIOSCIENCES LLC | 3 | $57 |
| ABBVIE INC. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Grifols USA, LLC | 1 | $22 |
Products named: DUPIXENT, XYWAV, Ohtuvayre, WAKIX, NUCALA, AVYCAZ, TRELEGY ELLIPTA, Prolastin-C Liquid.
Industry payments across NJ — which companies pay providers there.
